Novartis AG is 330.9x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $855.57 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OLMA | NVS |
|---|---|---|
| Market cap | $855.57 M | $283.13 B |
| US-listed rank | #2661 | #47 |
| Net income (latest FY) | -$162.45M | - |
| SEC filings | 538 | 947 |
Novartis AG is 330.9x more valuable than Olema Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $855.57 M).
Full pages: Olema Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.